Arbutus Biopharma Corp (ABUS) Executive Compensation
Arbutus Biopharma Corp (ABUS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ABUS
CIK: 1447028
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: A1
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerRyan Murray
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0000895421-26-000284 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-01 | FORM 4 | 0001447028-26-000061 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-01 | FORM 4 | 0001447028-26-000060 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-01 | FORM 4 | 0001447028-26-000059 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-01 | FORM 4 | 0001447028-26-000058 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-10-05 | — | SCHEDULE 13D/A Filing | 0001140361-26-038693 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | FORM 4 | 0001140361-26-038692 | View SEC Doc Filr Page |
| SC TO-I/A | 2026-10-01 | — | SC TO-I/A | 0001104659-26-112579 | View SEC Doc Filr Page |
| SC TO-I/A | 2026-09-30 | — | SC TO-I/A | 0001104659-26-112115 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-18 | FORM 4 | 0001447028-26-000053 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-18 | FORM 4 | 0001447028-26-000052 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-18 | FORM 4 | 0001447028-26-000051 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-18 | FORM 4 | 0001447028-26-000050 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-04 | — | SCHEDULE 13G Filing | 0000921895-26-002494 | View SEC Doc Filr Page |
| SC TO-I | 2026-08-24 | — | SC TO-I | 0001104659-26-100002 | View SEC Doc Filr Page |
| SC TO-C | 2026-08-21 | — | SC TO-C | 0001104659-26-099391 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-21 | FORM 8-K | 0001104659-26-099390 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000895421-26-000222 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001447028-26-000045 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | FORM 8-K | 0001171843-26-005442 | View SEC Doc Filr Page |
| 8-K | 2026-07-16 | 2026-07-15 | FORM 8-K | 0001171843-26-004708 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | FORM 4 | 0001447028-26-000040 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | FORM 4 | 0001447028-26-000039 | View SEC Doc Filr Page |
| S-8 | 2026-06-05 | — | S-8 | 0001447028-26-000027 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-26 | 8-K | 0001447028-26-000024 | View SEC Doc Filr Page |